Navigation Links
Pervasis Therapeutics Awarded Four Grants Under the Qualifying Therapeutic Discovery Project
Date:11/5/2010

CAMBRIDGE, Mass., Nov. 5, 2010 /PRNewswire/ -- Pervasis Therapeutics, Inc. today announced that it has been awarded over $920,000 in grants through the U.S. government's Qualifying Therapeutic Discovery Project, which provides tax credits and grants to projects that show significant potential to produce new therapies, reduce long-term health care costs, or significantly advance the goal of curing cancer within the next 30 years.  

Pervasis is a clinical stage company focused on developing breakthrough therapies with the potential to improve outcomes following common vascular surgical and interventional procedures, such as arteriovenous access, angioplasties, stents and peripheral and coronary bypass grafts—the failure of which result in serious complications and a significant increase in medical costs. There are no currently approved therapies that directly target the underlying physiological processes leading to serious vascular complications, including inflammation, thrombosis (the formation of a blood clot inside a blood vessel) and restenosis (the re-narrowing of a coronary artery after it has been treated with angioplasty or stenting).

Pervasis' therapies harness the power of the endothelium, the thin layer of cells that lines the interior surface of blood vessels, which has a well-understood role in regulating many of the body's healing processes, including vascular repair. Because these endothelial formulations secrete several key factors involved in combating inflammation and restenosis, they may also be applicable to other therapeutic fields where surgical or interventional procedures are required, including inflammatory disease, orthopedic injury and cancer.

The grants awarded to Pervasis span several therapeutic fields for which the company's therapies have application including:

  • Development of PVS-10200 for Peripheral Artery Disease ($244,479.25)
  • Development of Vascugel® to Sustain Arteriov
    '/>"/>

  • SOURCE Pervasis Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
    2. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
    3. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
    4. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
    5. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
    6. Cell Therapeutics Awarded $977,917 in Grants Under the Therapeutic Discovery Tax Credit Program
    7. Protalix BioTherapeutics Announces Preliminary Top-Line Positive Data from taliglucerase alfa Switchover Trial
    8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri®
    9. Shield Therapeutics Signs Agreement With AOP Orphan for ST10-021
    10. Echo Therapeutics to Present at the LifeTech Capital 1st Annual Miami Medical Investors Conference
    11. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... -- Integrated Silicon Solution, Inc. (Nasdaq: ISSI ... solutions, today announced that it will host its earnings ... a.m. Pacific Time (10:00 a.m. Eastern Time) to discuss ... quarter ended June 30, 2014. To access ... a.m. Pacific time on July 24, 2014.  The participant ...
    (Date:7/10/2014)... , July 10, 2014   Ventana Medical Systems, ... announced it has entered into an agreement with Merck ... as EMD Serono in the United States ... collaborate with Merck KGaA,s biopharmaceutical division on the development ... undisclosed target using Ventana,s proprietary diagnostic assays. In alignment ...
    (Date:1/15/2014)... 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today announced ... 2013, compared to sales of $2,202,000 for the prior year ... quarter has also shown growth over the preceding quarter,s sales, ... this fiscal year. Markets that experienced sales increases over the ...
    Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4
    ... CITY, Feb. 28, 2011 Concentra, a subsidiary of ... the future of occupational and urgent care through a ... experiences for clients and patients. Recent customer loyalty ratings ... of top U.S. consumer companies as a leader in ...
    ... ISLAND, N.Y., Feb. 28, 2011  A 67-year-old man with ... wife after wandering outside in near-freezing temperatures thanks to the ... watch-like EmSeeQ® wearable locator device. Robert ... discovered him missing. He was located on Victory Boulevard, more ...
    Cached Medicine Technology:Concentra is Writing a New Prescription on Health Care With Outstanding Service 2Concentra is Writing a New Prescription on Health Care With Outstanding Service 3Concentra is Writing a New Prescription on Health Care With Outstanding Service 4Concentra is Writing a New Prescription on Health Care With Outstanding Service 5Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 2Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 3
    (Date:7/10/2014)... widespread across the United States, due in large to ... of clinical data that will become available for research ... experts in healthcare have become increasingly focused on clinical ... purpose of gleaning insights that have the potential to ... that is known as big data. ...
    (Date:7/10/2014)... Adults with dyslexia are more likely to report that ... people who don,t have the learning disorder, according to ... to 10 percent of people, causes problems with reading ... with this condition said they suffered physical abuse during ... dyslexia. "Even after accounting for age, race, sex ...
    (Date:7/10/2014)... News) -- Men who have a vasectomy may be ... study suggests. But the risk is comparatively small, ... the study said more research is needed to determine ... the study, Harvard researchers analyzed data from more than ... starting in 1986. During that time, 6,023 cases of ...
    (Date:7/10/2014)... 2014In response to today,s announcement that the "Mississippi Baby," ... now been found to have detectable levels of the ... disappointment in this setback but remains hopeful that the ... remain undetectable for more than two years will continue ... ultimately develop a cure. , "Although we had ...
    (Date:7/10/2014)... device developed at the Massachusetts General Hospital (MGH) Center ... can be cultured to establish cell lines for genetic ... issue of Science , an MGH research team ... genetic mutation over time and changing susceptibility to therapeutic ... the blood that represent those present in metastatic deposits, ...
    Breaking Medicine News(10 mins):Health News:Six cases where big data can reduce healthcare costs 2Health News:Six cases where big data can reduce healthcare costs 3Health News:Six cases where big data can reduce healthcare costs 4Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 2Health News:Study Links Vasectomy to Aggressive Prostate Cancer 3Health News:Despite setback, 'Mississippi Baby' represents significant breakthrough in effort to end AIDS 2Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 2Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 3
    ... BALTIMORE, April 30 MDDCcommunity.com would like to announce ... local member company. Over the past few months Dynasplint(R) ... establishing more of a presence online. Their expansion includes ... Twitter account, all of which are intended to provide ...
    ... April 30 The Missouri House today amended ... funds to go to grants for maternity homes and pregnancy ... being considered by the Missouri Senate. , , ... homes and pregnancy resource centers are essential to helping pregnant ...
    ... The ,Help is Here Express, bus tour will be stopping ... 8th at various cities in order to help uninsured and ... for free or nearly free. With the state,s unemployment rate ... is ready to help state residents who face layoffs and ...
    ... YORK and NASSAU, The Bahamas, April 30 ... of Fincor (FINC) through a 1:1 share split. Prospero ... Technologies enlarges thru Fincor its portfolio with the new ... the WETTECH and Advanced Cavitation Technologies. Prospero ...
    ... are abandoned again! WEST PALM BEACH, Fla., April ... a civil rights and negligence lawsuit in New York ... Welfare Administration and four other agencies for failure to ... state-licensed foster parent.Identified in the filing only by their ...
    ... and psychological repercussions that impact quality of life and ... ability to remain employed. Compared to individuals with other ... have a more profound effect on a person,s ability ... of those with severe forms of arthritis were not ...
    Cached Medicine News:Health News:Dynasplint Systems, Inc. Launches Two New Web Sites Plus Social Media Tools 2Health News:Partnership for Prescription Assistance Prepared to Help Kansan Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Kansan Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Kansan Workers Hurt by Recession 4Health News:Prospero Group (PRPG) and Fincor (FINC) Made a Share Transfer and Enter the Market with ACTRx a New Malaria and Dengue Fever Treatment 2Health News:Severely Abused Foster Children Sue New York City Child Welfare Agencies After their Failure to Help Them 2Health News:Women with arthritis more likely than men to stop working 2Health News:Women with arthritis more likely than men to stop working 3
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: